(Q53589255)
Statements
Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis. (English)
C M Gudex
M R Hawthorne
A G Butler
P O Duffey
1 December 1997
12
6
675-684
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference